[1] Yang XW, Yan ZK, Gu ZM, et al. Studies on the chemical constituents of forbes Notopterygium (Notopterygium forbesii) [J]. Chin Pharm J, 1994, 29 (3): 141–143. [2] Yang XW, Yan ZK, Gu ZM, et al. Studies on the chemical constituents of incised Notopterygium (Notopterygium incisum ) [J]. Chin Tradit Herb Drugs, 1993, 24 (10): 507–511. [3] Gu ZM, ZhangDX, Yang XW, et al. Isolation of two new coumarin glycosides from N otopterygium forbesii and evaluation of a Chinese crude drug, Qiang-huo, the underground parts of N. incisum and N. forbesii, by high-performance liquid chromatography [J]. Chem Pharm Bull, 1990, 38 (9): 2498–2502. [4] Yang XW, Zhang P, Tao HY, et al. GC-MS analysis of essential oil constituents from the rhizome and root of Notopterygium incisum [J]. J Chin Pharm Sci, 2006, 15 (3): 172–177. [5] State Pharmacopoeia Committee of the People’s Republic of China. Pharm acopoeia of the People’s Republic of China [S]. 2000 Ed. Beijing: Chemical Industry Press, 2000. Appendix: 64. [6] Grassmann J. Terpenoids as p lant antioxidants [J]. Vitam Horm, 2005, 72: 505–535. [7] CalcabriniA, Stringaro A, ToccacieliL, et al. Terpinen-4-ol, the main component of M elaleuca alternifolia (tea tree) oil inhibits the in vitro growth of human melanoma cells [J]. J Invest Derm atol, 2004, 122 (2): 349–360. [8] Budhiraja SS, Cullum ME, Sioutis SS, et al. Biological activity of M elaleuca alternifolia ( tea tree ) oil component, terpinen-4-ol, in human myelocytic cell line HL-60 [J]. J M anipulative Physiol Ther, 1999, 22 (7): 447–453. [9] Hart PH, Brand C, Carson CF, et al. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes [J]. Inflamm Res, 2000, 49 (11): 619–626. [10] De-Oliveira AC, Ribeiro-Pinto LF, Paumgartten JR. In vitro inhibition of CYP2B1 monooxygenase by beta-myrcene and other mono terpenoid compounds [J]. Tox icol Lett, 1997, 92 (1): 39–46. [11] Asakura K, Kanemasa T, Minagawa K, et al. alpha-Eudesmol, a P/Q-type Ca2+ channel blocker, inhibits neurogenic vasodilation and extravasation following electrical stimulation of trigeminal ganglion [J]. Brain Res, 2000, 873 (1): 94–101. [12] Asakura K, Matsuo Y, Oshima T, et al. omega-Agatoxin IVA-sensitive Ca2+ channel blocker, alpha-eudesmol, protects against brain injury after focal ischemia in rats [J]. Eur J Pharm acol, 2000, 394: 57–65. [13] Kimura I. Medical benefits of using natural compounds and their derivatives having multip le pharmacological actions [J]. Yakugaku Zasshi, 2006, 126 (3): 133–143. [14] Hsieh TJ, Chang FR, Chia YC, et al. Cytotoxic constituents of the fruits of Cananga odorata [J]. J N at Prod, 2001, 64 (5): 616–619. |